Search Within
Document Type
273-486-7
Applied Filters:
Keyword:'273-486-7'
Showing 1-15 of 15 results for "273-486-7" within Technical Documents
XP725 Antibody Number-Lot Number 071M4826
455 456 477 478 479 480
6.1 481 482 483 484 505 506 507 508 529 530 531 532 553 554 555 556
6.2 485 486 487 488 509 510 511 512 533 534 535 536 557 558 559 560
6.3 489 490
Product Information Sheet-11093037001
zum Gewebe-Plasminogenaktivator (t-PA). Zeitschrift für die
Gesamte Innere Medizin. 1987;42:478-486.
• Verheijen JH, de Jong YF, Chang Gaubius GTG. Quantitative analysis of the composition of mixtures
In vitro generated extracellular matrix and fluid shear stress synergistically enhance 3D osteoblastic differentiation
2003) J. Biomed. Mater. Res. A 67, 191–199.
9. Liu, X. & Ma, P. X. (2004) Ann. Biomed. Eng. 32, 477–486.
10. Knabe, C., Driessens, F. C., Planell, J. A., Gildenhaar, R., Berger, G., Reif, D.,
Fitzner
XP725 Antibody List Lot 089K4791
M5187 4646 MYO6 P NP_004990.3 n/d n/d y
372 hnRNP M3-M4 R3777 4670 HNRNPM M NP_005959.2 y y y
486 NBS1 (Nibrin) N9287 4683 NBN M NP_002476.2 y n/d n/d
487 NBS1 (Nibrin) N3037 4683
XP725 Antibody List Lot 129K4831
M5187 4646 MYO6 P NP_004990.3 n/d n/d y
372 hnRNP M3-M4 R3777 4670 HNRNPM M NP_005959.2 y y y
486 NBS1 (Nibrin) N9287 4683 NBN M NP_002476.2 y n/d n/d
487 NBS1 (Nibrin) N3037 4683
XP725 Antibody List Lot 129K4830
M5187 4646 MYO6 P NP_004990.3 n/d n/d y
372 hnRNP M3-M4 R3777 4670 HNRNPM M NP_005959.2 y y y
486 NBS1 (Nibrin) N9287 4683 NBN M NP_002476.2 y n/d n/d
487 NBS1 (Nibrin) N3037 4683
Apoptosis - Antibodies, Reagents and Kits
Anti-FADD H M R Mk WB IP Rb 50 µg AB3102 $210
Anti-FADD, clone 1F7 H M WB M IgG1 100 µg 05-486 $319
FAS and FAS Ligand
FAS
Anti-Fas (human, activating), clone CH11
List of Antibodies
n/d y
483 Myosin Va M5062 P n/d n/d y
484 Myosin VI M0691 M y y y
485 Myosin VI M5187 P n/d n/d y
486 NBS1 (Nibrin) N9287 M y n/d n/d
487 NBS1 (Nibrin) N3037 P y n/d n/d
488 NBS1 (Nibrin) N3162
XP725 Worksheet for Lot Number 071M4826
1 2 E2F1 E8901
483 3 3 1 3 E2F2 E8776
484 3 3 1 4 E2F2 E8776
485 3 3 1 5 E2F3 E8651
486 3 3 1 6 E2F3 E8651
487 3 3 1 7 E2F4 E8526
488 3 3 1 8 E2F4 E8526
489
XP725 Antibody List
_236444.4,NP_004990.3,NP_001034635.1 M y y y
485 Myosin VI M5187 4646 MYO6 NP_004990.3 P n/d n/d y
486 NBS1 (Nibrin) N9287 4683 NBN NP_002476.2 M y n/d n/d
487 NBS1 (Nibrin) N3037 85482, 27354, 4683 NBN
XP725 Antibody List 013M4793
_236444.4,NP_004990.3,NP_001034635.1 M y y y
485 Myosin VI M5187 4646 MYO6 NP_004990.3 P n/d n/d y
486 NBS1 (Nibrin) N9287 4683 NBN NP_002476.2 M y n/d n/d
487 NBS1 (Nibrin) N3037 85482, 27354, 4683 NBN
MAPK: Antibodies, Proteins, Kits, siRNA and Reagents
200 µg 05-778
RhoE/Rnd3 4 H M WB IC ascites M IgG 200 µL 05-723
RhoG H M WB M IgG 100 µg 04-486
RhoGAP p190 D2D6 H M R Mk WB IP Pur M IgG 200
Inhibitor Sourcebook 3rd Edition
R., et al. 2001. Nat. Med. 7, 706.
Chuong, C.M., et al. 2000. Cell. Mol. Life Sci.57, 1692.
McMahon, A.P. 2000. Cell 100, 185.
Pepinsky, R.B., et al. 1998. J. Biol. Chem. 273, 14037.
Porter, J.A., et al
Halal Certificate
PROPIONATE W393304 C42599 HC-22SIQP12
485. CIS-3-HEXENYL TIGLATE W393118 C44276 HC-22SI5712
486. CIS-4-DECENAL 93%, STABILIZED W326402 B21092 HC-22SI8Q19
487. CIS-4-HEPTENAL 98%, FCC, FG W328901
Halal Certificate
PROPIONATE W393304 C42599 HC-24SI9J14
485. CIS-3-HEXENYL TIGLATE W393118 C44276 HC-24SIE214
486. CIS-4-DECENAL 93%, STABILIZED W326402 B21092 HC-24SIN721
487. CIS-4-HEPTENAL 98%, FCC, FG W328901